• 1. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

Introduction to 4-butylpyrrolidin-2-one (CAS No. 457893-17-3)

4-butylpyrrolidin-2-one, identified by the Chemical Abstracts Service Number (CAS No.) 457893-17-3, is a significant compound in the field of organic chemistry and pharmaceutical research. This heterocyclic ketone has garnered attention due to its versatile structural framework and potential applications in medicinal chemistry. The compound consists of a pyrrolidinone core, which is a seven-membered lactam, substituted with a butyl group at the 4-position and a carbonyl group at the 2-position. Such structural features make it a valuable scaffold for designing novel bioactive molecules.

The pyrrolidinone moiety is a privileged structure in drug discovery, often found in bioactive natural products and synthetic intermediates. Its rigid cyclic backbone, combined with the polar carbonyl group, facilitates interactions with biological targets such as enzymes and receptors. The butyl substituent at the 4-position introduces hydrophobicity, influencing solubility and binding affinity. These characteristics make 4-butylpyrrolidin-2-one a promising candidate for further derivatization and exploration in therapeutic development.

In recent years, there has been growing interest in 4-butylpyrrolidin-2-one due to its potential role in addressing various biological challenges. One of the most compelling areas of research involves its application as an intermediate in the synthesis of pharmacologically active agents. For instance, derivatives of this compound have been investigated for their antimicrobial, anti-inflammatory, and even anticancer properties. The presence of the pyrrolidinone ring allows for modifications that can fine-tune pharmacokinetic and pharmacodynamic profiles, making it an attractive building block for drug design.

Recent studies have highlighted the synthetic utility of 4-butylpyrrolidin-2-one in generating complex molecular architectures. Researchers have demonstrated its incorporation into more elaborate scaffolds through various chemical transformations, including nucleophilic additions, cyclizations, and functional group interconversions. These modifications have led to the discovery of novel compounds with enhanced biological activity. For example, certain derivatives have shown promise in preclinical models as modulators of neurotransmitter systems, which could have implications for treating neurological disorders.

The mechanistic insights into how 4-butylpyrrolidin-2-one interacts with biological targets have also been a focus of investigation. Computational studies have helped elucidate its binding modes within protein active sites, providing valuable insights for rational drug design. Additionally, experimental techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy have been employed to confirm these interactions at an atomic level. Such structural information is crucial for optimizing lead compounds into viable drugs.

Another area where 4-butylpyrrolidin-2-one has shown promise is in the development of agrochemicals. The unique structural features of this compound make it suitable for designing novel pesticides and herbicides that target specific biological pathways in pests while minimizing environmental impact. By leveraging its inherent reactivity and versatility, chemists are exploring ways to enhance crop protection strategies without compromising ecological balance.

The industrial synthesis of 4-butylpyrrolidin-2-one has also seen advancements, with researchers optimizing processes to improve yield and reduce environmental footprint. Green chemistry principles have been applied to develop more sustainable methods for producing this compound, including catalytic processes that minimize waste and energy consumption. These efforts align with global trends toward more sustainable chemical manufacturing practices.

In conclusion,4-butylpyrrolidin-2-one (CAS No. 457893-17-3) represents a fascinating compound with diverse applications across pharmaceuticals and agrochemicals. Its unique structural features—particularly the pyrrolidinone core and butyl substitution—make it a versatile scaffold for drug discovery and material science innovation. As research continues to uncover new possibilities for this molecule,4-butylpyrrolidin-2-one is poised to play an increasingly important role in addressing some of today's most pressing scientific challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)